Below are the most recent publications written about "Pancreaticoduodenectomy" by people in Profiles.
-
Zohar N, Gorgov E, Yeo TP, Lavu H, Bowne W, Yeo CJ, Nevler A. Incisional hernia after major pancreatic resection: long term risk assessment from two distinct sources - A large multi-institutional network and a single high-volume center. HPB (Oxford). 2024 Dec; 26(12):1487-1494.
-
Preston WA, Collins ML, G?nen M, Murtha T, Rivera V, Lamm R, Schafer M, Yarmohammadi H, Covey A, Brody LA, Topper S, Nevler A, Lavu H, Yeo CJ, Balachandran VP, Drebin JA, Soares KC, Wei AC, Kingham TP, D'Angelica MI, Jarnagin WR. Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy. JAMA Surg. 2024 Aug 01; 159(8):891-899.
-
Zheng R, Lam E, Altshuler P, Crutcher M, Lavu H, Yeo CJ, Stickle D, Leiby B, Kraft WK. Pharmacokinetics of apixaban in patients undergoing pancreaticoduodenectomy (PAP-UP). Int J Clin Pharmacol Ther. 2024 Jul; 62(7):319-325.
-
Uijterwijk BA, Lemmers DH, Ghidini M, Wilmink JW, Zaniboni A, Fusai GK, Zerbi A, Koerkamp BG, Luyer M, Ghorbani P, Salvia R, White S, Ielpo B, Goh BKP, Boggi U, Kazemier G, House MG, Mavroeidis VK, Bj?rnsson B, Mazzola M, Serradilla M, Korkolis D, Alseidi A, Roberts KJ, Soonawalla Z, Pessaux P, Fisher WE, Koek S, Kent TS, Vladimirov M, Bolm L, Jamieson N, Dalla Valle R, Kleeff J, Mazzotta A, Suarez Mu?oz MA, Cab?s SS, Ball CG, Berger AC, Ferarri C, Besselink MG, Hilal MA. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study. Br J Cancer. 2024 Jul; 131(1):117-125.
-
Geng AL, Thota B, Yellanki S, Chen H, Maguire R, Lavu H, Bowne W, Yeo CJ, Nevler A. Impact of antecolic vs transmesocolic reconstruction on delayed gastric emptying following pancreaticoduodenectomy. J Gastrointest Surg. 2024 06; 28(6):824-829.
-
Kuemmerli C, Balzano G, Bouwense SA, Braga M, Coolsen M, Daniel SK, Dervenis C, Falconi M, Hwang DW, Kagedan DJ, Kim SC, Lavu H, Nussbaum D, Partelli S, Passeri MJ, Pecorelli N, Pillarisetty VG, Pucci MJ, Sutcliffe RP, Tingstedt B, van der Kolk M, Vrochides D, Armstrong M, Wei A, Williamsson C, Yeo CJ, Zani S, Zouros E, Rozzini R, Abu Hilal M. Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta-analysis. J Hepatobiliary Pancreat Sci. 2024 May; 31(5):308-317.
-
D'Angelica MI, Ellis RJ, Liu JB, Brajcich BC, G?nen M, Thompson VM, Cohen ME, Seo SK, Zabor EC, Babicky ML, Bentrem DJ, Behrman SW, Bertens KA, Celinski SA, Chan CHF, Dillhoff M, Dixon MEB, Fernandez-Del Castillo C, Gholami S, House MG, Karanicolas PJ, Lavu H, Maithel SK, McAuliffe JC, Ott MJ, Reames BN, Sanford DE, Sarpel U, Scaife CL, Serrano PE, Smith T, Snyder RA, Talamonti MS, Weber SM, Yopp AC, Pitt HA, Ko CY. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA. 2023 05 09; 329(18):1579-1588.
-
Nerwal T, Qoshe L, Iyer S, Medina G, Felix A, Lavu H, Yeo CJ, Winter JM. Early Postoperative Vital Signs Predict Subsequent 90-Day Mortality After Pancreaticoduodenectomy. J Gastrointest Surg. 2023 08; 27(8):1660-1667.
-
Sholevar C, Torjani A, Kavanagh TR, Yudkoff C, Xiao K, Swaminathan V, Rshaidat H, Bowne WB, Krampitz GW, Nevler A, Yeo CJ, Lavu H. Euglycemic diabetic ketoacidosis (EDKA) after pancreaticoduodenectomy: An under-recognized metabolic abnormality with outcome implications. Surgery. 2023 04; 173(4):888-893.
-
Nauheim DO, Hackbart H, Papai E, Moskal D, Yeo CJ, Lavu H, Nevler A. Preoperative sarcopenia is a negative predictor for enhanced postoperative recovery after pancreaticoduodenectomy. Langenbecks Arch Surg. 2022 Sep; 407(6):2355-2362.